Cardiac Biomarkers Market, by Product Type (Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Troponins (T and I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory testing and Point of Care Testing), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Cardiac biomarkers are substances that are released into the blood when the heart is damaged or stressed. Measurements of these biomarkers are used to help diagnose acute coronary syndrome (ACS) and cardiac ischemia, conditions associated with insufficient blood flow to the heart. Tests for cardiac biomarkers can also be used to help determine a person’s risk of having these conditions or to help monitor and manage someone with suspected ACS and cardiac ischemia.
It is important to distinguish heart attacks from angina, heart failure, or other conditions that may have similar signs and symptoms because the treatments and monitoring requirements are different. Cardiac biomarker tests are used to detect the presence of ACS and cardiac ischemia and to evaluate their severity. The increase in one or more cardiac biomarkers in blood can identify people with ACS or cardiac ischemia, allowing rapid and accurate diagnosis and appropriate treatment of their condition.
Market Dynamics
Increasing prevalence of cardiovascular diseases and rising awareness in people across the globe is expected to fuel the market growth of cardiac biomarkers over the forecast period. For instance, according to the World Health Organization, in 2019 around 17.9 million deaths were reported globally due to cardiovascular diseases, out of which 85% deaths were caused due to strokes and heart attacks, while 32% of the globally reported deaths were caused due to other diseases, which makes cardiovascular disease as the top cause of death worldwide.
The increasing government initiatives to increase awareness about cardiovascular diseases is expected to drive the growth of global cardiac biomarkers market. For instance, in June 2020, the Australian government made an investment of AUD 29 million (US$ 22 million) under the Medical Research Future Fund’s (MRFF) Cardiovascular Health Mission. This was the first round of investment out of the total AUD 220 million (US$ 167 million) allotted for research in the management of cardiovascular diseases to prevent heart attack and stroke, which are the top most causes of death in Australia.
Key features of the study:
- This report provides in-depth analysis of the global cardiac biomarkers market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Randox Laboratories Ltd, Siemens Healthineers, and BioMerieux SA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The cardiac biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac biomarkers market
- Global Cardiac Biomarkers Market, By Product Type:
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobulin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- Global Cardiac Biomarkers Market, By Application:
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- Global Cardiac Biomarkers Market, By Location of Testing:
- Laboratory Testing
- Point-of-Care Testing
- Global Cardiac Biomarkers Market, By Region:
- North America
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country:
- U.S.
- Canada
- Latin America
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Myocardial Muscle Creatine Kinase (CK-MB)
- Troponins (T and I)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- By Location Of Testing
- Laboratory Testing
- Point-of-Care Testing
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles :
- Abbott Laboratories
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Randox Laboratories Ltd
- Siemens Healthineers
- BioMérieux SA
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Location of Testing
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Porters Five Forces analysis
- Market Trends
- Key highlights
- Supply chain analysis
- Epidemiology
- Regulatory scenario
- PEST Analysis
- 4. Global Cardiac biomarkers market COVID-19 impact analysis
- Economic Impact of COVID-19 on healthcare sector
- Impact on cardiac biomarkers market
- Impact on demand and supply of cardiac biomarker
- 5. Global Cardiac biomarkers market, by Product Type,2017 –2028 (US$ Million
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Myocardial Muscle Creatine Kinase (CK-MB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn
- Troponins (T and I)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Myoglobin
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million
- Ischemia-modified Albumin (IMA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- 6. Global Cardiac Biomarkers Market, By Application, 2017 –2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Congestive Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Acute Coronary Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Atherosclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- 7. Global Cardiac Biomarkers Market, By Location of Testing, 2017 –2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Laboratory Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Point-of-Care Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- 8. Global Cardiac Biomarkers Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 9. Company Profiles
- Abbott laboratories
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Randox Laboratories Ltd.
- Siemens Healthineers
- BioMérieux SA
- 10. Section
- Research Methodology
- About us and services
- Contact
- *Browse 35 market data tables and 35 figures on "Cardiac Biomarkers Market” - Global forecast to 2028
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook